Literature DB >> 12836456

Cost-effectiveness in diagnosis of patients with long-standing fever.

Harald Wolf1, Wolfgang Graninger.   

Abstract

INTRODUCTION: It is difficult to make an adequate diagnosis regarding patients with fever of unknown origin (FUO). The cases require time-consuming and costly investigations. Our study features a cost-effectiveness analysis and the development of an alternative diagnostic model. The diagnostic programmes include: serological and microbiological tests, blood laboratory test, radiological, histopathological and radionuclide tests. PATIENTS AND METHODS: For 100 hospitalized patients with fever (group A: > 38.0 degrees C for as long as 7 days; group B: > 38.3 degrees C for 3 weeks), the various results of clinical investigations were obtained, and the costs of a three-step programme for the four main diagnoses, including the diagnostic value, were evaluated.
RESULTS: There was no significant difference between male and female patients, or patients < 35 vs. > 35, and < 50 vs. > 50 years. Infections were found in 46%, neoplasma and collagen-vascular disease/autoimmune disorders in 10% each, and other diseases in 20% of all patients. The third diagnostic programme was the most expensive in all four disease categories. In total, 30, 34, and 22 patients were diagnosed by the three diagnostic steps, respectively. In 14 patients no diagnosis was found. The overall cost of the three diagnostic programmes was 359, 1,996 and 3,496 EUR, respectively.
CONCLUSIONS: In the majority of the cases (64%), the first and second diagnostic programmes result in a diagnosis. The investigations of the third diagnostic programme are more accurate, more expensive, and result in a diagnosis, mainly in patients of group B. Our proposed new diagnostic model would save 134, 746, and 558 EUR for each diagnostic step, respectively.

Entities:  

Mesh:

Year:  2003        PMID: 12836456     DOI: 10.1046/j.1563-258x.2003.02112.x

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  21 in total

1.  Fever of unexplained origin: report on 100 cases.

Authors:  R G PETERSDORF; P B BEESON
Journal:  Medicine (Baltimore)       Date:  1961-02       Impact factor: 1.889

Review 2.  1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America.

Authors:  W T Hughes; D Armstrong; G P Bodey; A E Brown; J E Edwards; R Feld; P Pizzo; K V Rolston; J L Shenep; L S Young
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

Review 3.  Fever of unknown origin in adults.

Authors:  J V Hirschmann
Journal:  Clin Infect Dis       Date:  1997-03       Impact factor: 9.079

Review 4.  Fever of unknown origin.

Authors:  J L Brusch; L Weinstein
Journal:  Med Clin North Am       Date:  1988-09       Impact factor: 5.456

5.  Fever of undetermined origin: diagnosis and follow-up of 105 cases, 1970-1980.

Authors:  E B Larson; H J Featherstone; R G Petersdorf
Journal:  Medicine (Baltimore)       Date:  1982-09       Impact factor: 1.889

Review 6.  Fever in the ICU.

Authors:  P E Marik
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

Review 7.  [Febrile neutropenia: practical aspects].

Authors:  P Harten; B Seyfarth; N Schmitz
Journal:  Med Klin (Munich)       Date:  1998-10-15

8.  [Recurrent fever of unknown etiology lasting more than 6 months. Report on 85 patients].

Authors:  G Winckelmann; A Lütke; J Löhner
Journal:  Dtsch Med Wochenschr       Date:  1982-07-02       Impact factor: 0.628

Review 9.  Diagnostic strategy for fever of unknown origin in the ultrasonography and computed tomography era.

Authors:  D C Knockaert
Journal:  Acta Clin Belg       Date:  1992       Impact factor: 1.264

10.  Fever of unknown origin in the elderly.

Authors:  A L Esposito; R A Gleckman
Journal:  J Am Geriatr Soc       Date:  1978-11       Impact factor: 5.562

View more
  1 in total

1.  Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin.

Authors:  Raffaele Manna; Roberto Cauda; Sandro Feriozzi; Giovanni Gambaro; Antonio Gasbarrini; Didier Lacombe; Avi Livneh; Alberto Martini; Huri Ozdogan; Antonio Pisani; Eleonora Riccio; Elena Verrecchia; Lorenzo Dagna
Journal:  Intern Emerg Med       Date:  2017-07-19       Impact factor: 3.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.